300294.SZ
Price:
$15.74
Market Cap:
$7.94B
Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The company is engaged in the research, development, production, and sale of a diverse portfolio, primarily focusing on blood products, diabetes medications, and various biochemical and chemical pharmaceuticals. Its extensive range of blood-derived products includes human fibrinogen, human albumin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, and freeze-dried intravenous human immunoglobulin. For diabetes management, t...[Read more]
Industry
Biotechnology
IPO Date
2012-03-08
Stock Exchange
SHZ
Ticker
300294.SZ
According to China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 139.05. This represents a change of 327.17% compared to the average of 32.55 of the last 4 quarters.
The mean historical PE Ratio of China Resources Boya Bio-pharmaceutical Group Co., Ltd. over the last ten years is 48.39. The current 139.05 PE Ratio has changed 28.63% with respect to the historical average. Over the past ten years (40 quarters), 300294.SZ's PE Ratio was at its highest in in the December 2022 quarter at 331.16. The PE Ratio was at its lowest in in the December 2024 quarter at -242.63.
Average
48.39
Median
40.42
Minimum
22.83
Maximum
102.73
Discovering the peaks and valleys of China Resources Boya Bio-pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 168.01%
Maximum Annual PE Ratio = 102.73
Minimum Annual Increase = -45.71%
Minimum Annual PE Ratio = 22.83
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 102.73 | 168.01% |
| 2024 | 38.33 | -45.71% |
| 2023 | 70.60 | 66.06% |
| 2022 | 42.51 | -12.43% |
| 2021 | 48.54 | -11.71% |
| 2020 | 54.98 | 76.06% |
| 2019 | 31.23 | 36.80% |
| 2018 | 22.83 | -35.40% |
| 2017 | 35.34 | -4.06% |
| 2016 | 36.83 | -37.55% |
The current PE Ratio of China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
70.55
5-year avg
60.54
10-year avg
48.39
China Resources Boya Bio-pharmaceutical Group Co., Ltd.’s PE Ratio is greater than Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (28.94), greater than Hualan Biological Bacterin Inc. (56.75), greater than Zhejiang Jolly Pharmaceutical Co.,LTD (15.49), greater than Tibet Cheezheng Tibetan Medicine Co., Ltd. (17.01), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (15.64), greater than Shanghai Haohai Biological Technology Co., Ltd. (32.11), greater than Jinyu Bio-technology Co., Ltd. (107.15), greater than Chengdu Easton Biopharmaceuticals Co., Ltd. (31.18), greater than Sansure Biotech Inc. (59.92), greater than Chengdu Kanghua Biological Products Co., Ltd. (27.93),
| Company | PE Ratio | Market cap |
|---|---|---|
| 28.94 | $8.87B | |
| 56.75 | $10.73B | |
| 15.49 | $10.09B | |
| 17.01 | $11.77B | |
| 15.64 | $7.28B | |
| 32.11 | $6.23B | |
| 107.15 | $15.45B | |
| 31.18 | $8.70B | |
| 59.92 | $9.03B | |
| 27.93 | $6.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Resources Boya Bio-pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like China Resources Boya Bio-pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is China Resources Boya Bio-pharmaceutical Group Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
What is the highest PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
What is the 3-year average PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
What is the 5-year average PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)?
How does the current PE Ratio for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) compare to its historical average?